F00.1 F01.0
Conditions
Interventions
Group 1: At baseline, day seven and day 14, the EQ-5D-5L will be administered via face to face interviews by dementia-specific qualified nurses at patients’ or caregivers’ homes. Both patients (self-r
Sponsors
EuroQol Research Foundation
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: The following inclusion criteria should be met: positively screened for dementia through the DemTect procedure (DemTect =8) or formally diagnosed with dementia by a treating GP, neurologist or psychiatrist. Eligibility criteria for caregivers are as follows: living in the same household with the person with dementia or being at least once a day in contact with the person with dementia.
Exclusion criteria
Exclusion criteria: Patients without dementia diagnosis or DemTect >8
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes are i) to quantify the occurrence, frequency and intensity of health fluctuations and the underlying health events over a 14-day period and ii) to identify HRQoL dimensions that are affected by these health fluctuations. | — |
Secondary
| Measure | Time frame |
|---|---|
| As secondary outcomes this study tries to evaluate if past fluctuations are considered in the assessment of health today using the EQ-5D-5L and if latter is true to determine which recall period would be more appropriate to capture health fluctuation in dementia. | — |
Countries
Germany
Contacts
Public ContactNiklas Weber
Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE) - AG Translationale Versorgungsforschung
Outcome results
None listed